Table 2.

AICDA mRNA Expression and Ig-Isotype Secretion of Peripheral Blood Mononuclear Cells from Graves' Disease Patients and Controls During Epstein–Barr Virus-Reactivation Induction

	Day 0	Day 5	Day 10	Day 12
AICDA mRNAa
Controls	0.005	0.062	0.011	0.029
Patients	0.003	0.025	0.018	0.041
p	0.522	0.331	0.230	0.131
Total IgG (ng/mL)
Controls	17.696	7.310	13.614	10.118
Patients	16.769	9.911	14.367	9.948
p	0.882	0.882	0.552	0.71
Total IgM (ng/mL)
Controls	53.502	39.181	20.87	33.546
Patients	54.562	35.704	18.195	26.275
p	0.603	0.152	0.824	0.025b
Total IgE (ng/mL)
Controls	12.993	8.200	4.511	10.478
Patients	11.424	7.215	5.526	11.491
p	0.201	0.080	0.112	0.261

^aAICDA mRNA relative quantity (normalized to β-actin).

^bSignificant.

EBV, Epstein–Barr virus.